Molecular chaperone α-crystallin prevents detrimental effects of neuroinflammation  by Masilamoni, J.G. et al.
1762 (2006) 284–293
http://www.elsevier.com/locate/bbaBiochimica et Biophysica ActaMolecular chaperone α-crystallin prevents detrimental effects
of neuroinflammation
J.G. Masilamoni a, E.P. Jesudason a, B'joe Baben b, Charles E. Jebaraj c,
S. Dhandayuthapani a, R. Jayakumar a,⁎
a Bio-Organic and Neurochemistry Laboratory, Central Leather Research Institute, Adyar, Chennai-600 020, India
b Department of Biochemistry, Sri Ramachandra Medical College and Research Institute, (Deemed University), Chennai-600 116, India
c Department of Biotechnology, Sri Ramachandra Medical College and Research Institute, (Deemed University), Chennai-600 116, India
Received 11 April 2005; received in revised form 3 November 2005; accepted 11 November 2005
Available online 27 December 2005Abstract
Silver nitrate administration stimulates immune activation, inflammation and deterioration in cell function. It is well established that hippocampal
and cortical tissue are susceptible to degeneration in responses to insult such as oxidative stress or infection. This study was designed to investigate
the prophylactic effect of α-crystallin, a major chaperone lens protein comprising of α-A and α-B subunits in inflammation induced mice. Mice were
divided into three groups (n=6 in each), control, inflammation and α-crystallin treated. Our result shows that α-crystallin pretreatment effectively
diminished systemic inflammation induced glial fibrillary acidic protein (GFAP) and nuclear factor kappa B (NFκB) expression in the mice
neocortex, reversed elevated intracellular calcium levels, acetylcholine esterase activity and depletion of glucose. Furthermore it also significantly
prevented nitric oxide (Pb0.05) and lipid peroxide production in the plasma, liver, neocortex and hippocampus of the inflammation-induced mice. In
order to demonstrate the direct SOH and nitric oxide radical scavenging ability of α-crystallin, an In vitro experiment using primary astrocyte culture
subjected to lipopolysaccharide (LPS), a well-known inflammatory stimuli were also carried out. This study reiterates that α-crystallin therapy may
serve as a potent pharmacological agent in neuroinflammation.
© 2005 Elsevier B.V. All rights reserved.Keywords: α-Crystallin; Neuroinflammation; Nitric oxide; Lipid peroxide; Glial fibrillary acidic protein; Nuclear factor kappa-B; Calcium; Acetylcholine;
Lipopolysaccharide1. Introduction
Inflammation is a natural response to disturbed homeostasis
caused by infection, injury or trauma. The host responds with a
complex series of immune reactions from neutralizing invading
pathogens, repairing injured tissues to promoting wound
healing [1,2]. The onset of inflammation is characterized by
release of several pro-inflammatory mediators like tumor
necrosis factor (TNF), interleukin (IL)-1, adhesion molecules,
vasoactive mediators, and reactive oxygen species [1–3]. The
early release of pro-inflammatory cytokines by activated
macrophages has a pivotal role in triggering the local
inflammatory response [2]. These pro-inflammatory agents⁎ Corresponding author. Tel.: +91 44 24911386x324; fax: +91 44 24911589.
E-mail address: karkuvi77@yahoo.co.uk (R. Jayakumar).
0925-4439/$ - see front matter © 2005 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbadis.2005.11.007enter the brain at circumventricular site, an area that lack a
functional blood brain barrier and activate glial cells [3].
Astrocytes, together with microglia, are the main effectors cells
of innate immune response in the central nervous system (CNS)
and can be activated in neurodegenerative diseases to produce an
array of inflammatory mediators [4,5]. Excessive production of
these inflammatory mediators, which including glial-derived
cytokines like IL-1β and reactive oxygen species (ROS) like
nitric oxide (NO) can contribute to neuroinflammation, which
may be responsible for the degeneration of basal forebrain
cholinergic cells [6]. For example, head trauma in humans is a
significant risk factor for Alzheimer's disease (AD) [7] and is
associated with increased levels of inflammatory proteins [8] and
a decline in the number of basal forebrain cholinergic neurons [9].
α-Crystallin, a member of the small heat shock protein
family of molecular chaperones, is an aggregate of two
polypeptides, α-A and α-B crystallins in a 3:1 ratio. α-A
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crystallin is found in many other tissues such as kidney, heart,
skeletal muscle, liver, brain, placenta and lungs. Moreover, it
may be upregulated in response to physiological or pathological
stress associated with neurodegenerative diseases [10]. α-
Crystallin protects many enzymes from inactivation and heat-
induced aggregation [11]. In our earlier study, we have reported
that α-crystallin ameliorates inflammation-induced oxidants by
rescuing the antioxidant enzymes [12]. The present study
focuses to investigate the efficacy of α-crystallin to prevent
neuroinflammation using in vivo and in vitro models.
2. Materials and methods
Male albino mice 6–8 weeks old weighing 25–30 g were obtained from
Tamilnadu veterinary and Animal Sciences University, Madhavaram, Chennai,
Tamilnadu, India. The animals were maintained in the Poly acrylic cages under
hygienic conditions at normal room temperature (28–30 °C) on a 12-h light/dark
cycle. The animals were fed with commercial pellet diet (Hindustan lever Ltd.,
Bangalore, India) and had free access to water. The surgical procedures were
performed as per NIH animal ethical guidelines, approved by the animal care
committee of Central Leather Research Institute, Chennai, Tamilnadu.
2.1. Isolation and purification of bovine α-crystallin
Eye lens capsules were removed form bovine eyes obtained from local
slaughterhouse. These lenses were mixed with a three-fold quantity of 0.1M Tris
buffer (containing 100mMNaCl, 1mMEDTA, and 0.1% sodium azide pH 7.4 at
4 °C and gently homogenized [13]. The mixture was gently stirred overnight and
the soluble fraction was decanted from the remaining insoluble part of the lens.
After centrifugation at 6000×g for 30 min, the supernatant was collected and its
absorbance measured at 280 nm. One unit of absorbance was taken as equivalent
to 1 mg of protein per ml in the lens extract. The extract was distributed in
aliquots and conserved at −20 °C. Purification was done using 0.8×50 Sephacryl
S-200 column equilibrated at 4 °C with eluting buffer (contains Tris 0.1 mM,
NaCl 0.2 M, pH 7.2). The eluted protein was collected and filtrated through a
Sartorious membrane (cutoff 100,000) and the concentrated fraction was
dialyzed against distilled water. They are aliquotted, and conserved at −20 °C.
The purity of α-crystallin was confirmed by 12% SDS-PAGE [14].
2.1.1. Experimental design
The animals were divided in to three groups; each group consists of six
animals. Group I: (Control) Mice were given physiological saline (0.5 ml)
subcutaneously. Group II: (Inflammation) Mice were given single subcutaneous
injection of 0.5 ml 2% silver nitrate. The dosage was fixed on the basis of our
previous reports [12,32]. Group III: (α-Crystallin Treated) Mice were
intraperitoneally administered α-crystallin (50 μg/100 g body weight). The
effective dosage was fixed on the basis of our previous reports [12,32]. Three
hours later, inflammatory stimuli were induced by a single subcutaneous
injection of 0.5 ml 2% silver nitrate.
Animals were sacrificed by cervical decapitation after 24 h of silver nitrate
injection. The liver, hippocampus and neocortex were rapidly micro dissected
and homogenized in 0.1 M Tris buffer pH 7.4. The homogenate was then
centrifuged at 5000×g for 10 min (4 °C), and the supernatant was used for all the
estimations. Blood was collected in heparinised vial and plasma was separated
by centrifugation (2000×g, 10 min) at 4 °C.
2.2. Immunohistochemical analysis of GFAP and NFκB
Under deep anesthesia, the mice were perfused transcardially with ice-cold
paraformaldehyde solution (4% in phosphate buffer, pH 7.4). The liver and brain
were post fixed for 4 h and cryoprotected in 18% sucrose solution for at least 48
h. The liver and hippocampus were cut in a cryostat in 10 μ thick coronal
sections, placed in phosphate-buffered saline (PBS) containing 0.1% sodium
azide, and stored at 4 °C until used for immunohistochemistry.2.2.1. Antibodies
GFAP was detected by means of mouse monoclonal mouse antibody (1:
1000 dilution Oncogene research products). NFκB (p65, Rel A) (Ab-1) was
detected by means of a rabbit polyclonal antibody (1:500, Oncogene research
products).
2.3. Nitric oxide (NO)
The presence of nitrite, a stable oxidized product of nitric oxide (NO), was
determined as per method described by Kim et al. [15]. 100 μl of liver,
neocortex, hippocampus homogenates and plasma were drawn, to it was added
100 μl sulfanilamide (1%) in 5% H3PO4 and 100 μl of 0.1% N-(1-napthyl)
ethylenediamine dihydrochloride in water were added to each well of 96-well
microtitre plate. OD was immediately measured at 550 nm using ELISA reader
(Biotek Instruments, USA). Nitrite concentration in the supernatant was
determined using calibration curve of sodium nitrite.
2.4. Determination of lipid peroxides
Lipid peroxides were measured as malondialdehyde (MDA) products, using
the high performance liquid chromatography (HPLC) acetonitrile precipitation
assay [16]. Briefly, aliquots of plasma, liver, neocortex and hippocampus in
buffer were mixed with equal volume of acetonitrile, homogenized and
centrifuged to precipitate the proteins. The supernatants were then filtered
through millipore membrane (0.2 μm) and 20 μl of samples was injected by
Hamilton syringe in the HPLC for detection of MDA. The MDAwas identified
by comparing the retention time (RT) with the standards, 1,1′,3,3′-tetra-
methoxy-propane run under identical conditions.
2.5. Spin trapping the hydroxyl radical with DMPO and α-crystallin
The rate constant for the reaction of α-crystallin with SOH was determined
by the method of Matuszak with slight modifications [17]. Briefly, 5 μl DMPO
(final conc. 30 μM), 20 μl of 10 mM H2O2 (final concentration, 500 μM), and
bovine serum albumin (BSA) or various concentrations of α-crystallin (1 μg,
1.5 μg, 2 μg) were dissolved in air-saturated 0.1 M phosphate buffer (pH 7.0).
BSA a hydroxyl radical scavenger was used as a positive control [18]. The
reaction was initiated by the addition of 30 μl of 1 mM ferrous ammonium
sulfate (final conc. 0.1 mM) to the reaction mixture. The final volume of every
sample was adjusted to 400 μl. The sample solution was transferred to a flat
quartz EPR cell (Labotec Co., Ltd., Tokyo, Japan), which was, in turn, placed
in the cavity of the EPR spectrometer (JES-TE 300, JEOL Co., Ltd., Tokyo,
Japan) equipped with a cavity ES-UCX2, JEOL) at X-band (9.5 GHz). The
position of EPR cell in the cavity was fixed for reproducibility. EPR
measurements were started 40 s after the addition of ferrous ammonium
sulfate. When ferrous ammonium sulfate is mixed with H2O2,
SOH occurs by
the Fenton reaction.
To investigate the direct specific therapeutic action of α-crystallin over the
inflammation induction we carried out the following in vivo experiments using
primary astrocytes subjected to LPS. It has been well documented that microbial
products, such as endotoxin-derived LPS, can initiate an inflammatory response
[19].
2.6. Primary astrocytes culture
Astrocytes were isolated from the forebrain of the experimental mice
neonatal mice cerebra by a modified collagenase perfusion technique [20] with
slight modifications. Briefly, 1-day-old neonatal Swiss-albino mice were
decapitated and the forebrains were dissected out. After removal of the
meninges and the blood vessels, the cerebral cortices were collected and minced
with scalpel in a solution containing 20 μg/ml DNase and 0.3% BSA in HBSS.
This was centrifuged and incubated in a solution containing 0.025% trypsin,
0.1% collagenase and 0.3% BSA in HBSS at 37 °C. After the trypsin had been
neutralized in Dulbecco's modified Eagle's medium (DMEM; Sigma-Aldrich)
containing 10% fetal bovine serum (FBS; BioWhittaker, Walkersville, MD,
USA) and penicillin–streptomycin solution, the cells were rinsed and seeded
into 25-cm2 tissue culture flasks. The culture became almost confluent 4–5 days
Fig. 1. Blockade of the silver nitrate-induced increase in GFAP immunoreactivity
by α-crystallin pretreatment from the neocortex section. (a) Mice were given
physiological saline (0.5 ml) subcutaneously. (b) Mice were given subcutaneous
injection of 0.5 ml 2% silver nitrate. (c)Mice were intraperitoneally administered
α-crystallin 3 h before 2% silver nitrate-induced inflammation. Immunohisto-
chemical stain ×40.
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Finally, the cells were seeded at a density of 105 cells/cm2 in 6-well plates. After
3 days the cells were confluent and were divided in to three groups.
Group A: (Control) Confluent culture of astrocyte cells.
Group B: (LPS treated) Confluent culture of astrocyte cells incubated with
5 ng/l LPS (from E. coli, serotype 055:B5) for 3 h.
Group C: (α-Crystallin pretreated) 2 μg α-crystallin was added to the confluent
culture of astrocyte cells and incubated for 3 h, subsequently 5 ng/l LPS
(from E. coli, serotype 055:B5) and further incubated for 3 h.
Astrocytes were washed with PBS and used for the following analysis such
as EPR, in vitro lipid peroxidation studies and NO.
2.7. Lymphocyte isolation
Lymphocytes were isolated from the experimental mice according to the method
of Thorsby and Bratlie [21]. Blood sample were collected in a heparinised vial and it
was diluted with equal volume of Hanks balanced salt solution (HBSS). The diluted
blood sample were carefully layered over 3 ml of Ficoll gradient and centrifuged at
800×g for 20min at room temperature. After completion of centrifugation process the
lymphocytes form a distinct band, which was removed from the interface.
Approximately 8.5×106 cells/ml were used for Ca2+ quantification.
2.8. Hepatocyte isolation
Hepatocytes were isolated from the liver of the experimental mice by a
modified collagenase perfusion technique [22]. An apical piece of liver was
perfused with 100 ml pre-perfusion solution (Earle's balanced salt solution
without calcium, with 0.7 mM EGTA) for 20-min, followed by perfusion for
20 min with 80 ml collagenase D (0.5 mg/ml; Boehringer). Cells were
filtered and hepatocytes were separated from non-parenchymal cells by low-
speed centrifugation. Approximately 8.5×106 cells/ml were used for Ca2+
quantification.
2.9. Astrocytes isolation
Astrocytes were isolated from the forebrain of the experimental mice by a
modified collagenase perfusion technique [20]. One hundred mg of forebrain
were removed from experiment animals and minced with scalpel in a solution
containing 20 μg/ml DNase and 0.3% BSA in HBSS. This was centrifuged and
incubated in a solution containing 0.025% trypsin, 0.1% collagenase and 0.3%
BSA in HBSS in a water bath at 37 °C. After 15 min the resulting mixer was
centrifuged and the pellet was agitated 5 times with a Pasteur pipette.
Supernatant was collected after 4 min. Approximately 8.5×106 cells/ml were
used for Ca2+ quantification.
2.10. Intracellular Ca2+ determination
The above isolated lymphocytes, hepatocytes and astrocytes were loaded
with FURA-2AM (1 μM) for 30 min, rinsed three times in a HEPES buffer (25
mM HEPES; 125 mM NaCl; 5.9 mMKCl; 1.28 mM CaCl2 1.1 mMMgCl2) and
allowed to equilibrate for 20 min in the HEPES medium at room temperature.
The cells were rinsed again, resuspended in the HEPES medium at the con-
centration of 0.5×106 cells/ml, and transferred to a cuvette for the measurement
of calcium. The cytoplasmic Ca2+ concentration ([Ca2+]i) was measured by dual
wavelength spectrophotofluorimetry in a Perkin-Elmer LS-50 spectrophoto-
fluorometer as previously described [23]. The excitation wavelength was
continuously altered between 340 and 380 nm, and the emission wavelength was
490 nm. The ([Ca2+]i) was calculated form the recorded fluorescence ratios of
350/380 nm according to the previously described formula [24].
2.11. Glucose
The brain glucose was estimated by the O-toluidine colour reaction of
Dubowski modified by Sasaki and Mataui [25]. The glucose reacts readily withO-toluidine reagent in the presence of acid to form a colored complex, which has
absorption maxima at 640 nm.
2.12. Acetylcholinesterase (AChE)
The activity of AChE will be measured according to a method was
developed by Ellman et al. [26]. This method employs acetylthiocholine
iodide (ATChI) as a synthetic substrate for AChE. ATChI is broken
down to thiocholine and acetate by AChE and thiocholine is reacted
with dithiobisnitrobenzoate (DTNB) to produce a yellow color. The
quantity of yellow color, which develops over time, is a measure of the
activity of AChE and can be measured using a spectrophotometer at
412 nm.
Fig. 2. Blockade of the silver nitrate-induced increase inNFκB immunoreactivity
by α-crystallin pretreatment from the neocortex section. (a) Mice were given
physiological saline (0.5 ml) subcutaneously. (b) Mice were given subcutaneous
injection of 0.5 ml 2% silver nitrate. (c)Mice were intraperitoneally administered
α-crystallin 3 h before silver nitrate-induced inflammation. Immunohistochem-
ical stain ×40.
Fig. 3. Blockade of the silver nitrate-induced increase in NFκB immunoreactivity
by α-crystallin pretreatment from the liver section. (a) Mice were given
physiological saline (0.5 ml) subcutaneously. (b) Mice were given subcutaneous
injection of 0.5 ml 2% silver nitrate. (c)Mice were intraperitoneally administered
α-crystallin 3 h before silver nitrate-induced inflammation. Immunohistochem-
ical stain ×40.
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Acetylcholine was estimated by the following procedure of Hestrin [27].
Hydroxylamine at alkaline pH rapidly converts acetylcholine into hydramic
acid. This hydramic acid is a direct function of acetylcholine content, which was
measured at 540 nm.
2.13.1. Statistical analysis
Results were statistically evaluated using one-way analysis of variance
(ANOVA) followed by the Tukey's test was applied to determine the significant
differences among the groups. P values less than 0.05 were considered significant.3. Results
3.1. GFAP and NFκB immunoreactivity
In the neocortex, the immunoreactivity of GFAP, an index of
astroglial response to neuronal injury was increased by silver
nitrate induced inflammation (Fig. 1b). Our immunohistochem-
ical analysis of neocortex and liver tissue sections revealed that
NFκB, a key factor for the control of different cellular pathways
involved in inflammation, proliferation and regulation of
apoptosis expression was increased in the inflammation-
induced mice (Figs. 2b and 3b). α-Crystallin pretreatment
Table 1
HPLC determination of MDA and conjugated dienes in plasma, liver, neocortex
and hippocampus of control, inflammation induced and α-crystallin pretreated
mice
Parameter Control Inflammation α-Crystallin
Plasma (nmols MDA/mg protein) 10.05±0.86a 16.02±1.05b 11.21±1.10a
Percentage variation of MDA
production compared to control
– 40.49 9.55
Liver (nmols MDA/mg protein) 24.95±1.91a 34.51±3.14b 26.95±2.09a
Percentage variation of MDA
production compared to control
– 46.33 8.01
Neocortex (nmols MDA/
mg protein)
34.55±3.21a 44.36±3.8b 37.18±3.81a
Percentage variation of MDA
production compared to control
– 57.37 7.61
Hippocampus (nmols
MDA/mg protein)
29.73±2.58a 38.75±3.66b 31.54±3.45a
Percentage variation of MDA
production compared to control
– 50.52 6.08
Values represent the group means±S.D. for six animals. Different superscripts
within a row show significant variation between groups, Pb0.05.
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(Fig. 1c) and NFκB immunoreactivities (Figs. 2c and 3c).
3.2. Nitric oxide
NO is a reactive free radical that plays a functional regulatory
role in immunological response, vascular tone, memory, pain,
olfaction and neurotransmitters release [28]. Although NO has
useful properties, it is also toxic under some conditions and may
contribute to several neurological diseases. Our result shows
that NO concentration was significantly higher (Pb0.05) in the
plasma, liver, neocortex and hippocampus of the inflammation-
induced mice when compared to control and α-crystallin-
pretreated mice (Fig. 4). α-Crystallin pretreatment significantly
prevent NO production in the plasma, liver, neocortex and
hippocampus of the inflammation-induced mice.
There is a growing body of evidence showing that acute
inflammation is mediated by free radical damage to cell mem-
branes [29,30]. Elevated concentrations of MDA (Pb0.001)
were recorded in plasma, liver, neocortex and hippocampus of
inflammation induced mice when compared to the control and
α-crystallin pretreated mice (Table 1). The present data shows
that inflammation induced mice has 40%, 46%, 57% and 51%
increase in the concentration of MDA of plasma, liver,
neocortex and hippocampus, respectively, when compared to
controls. The levels of MDA and diene conjugates were nor-
malized in the α-crystallin treated mice (Table 1). α-Crystallin
therapy to the inflammation induced mice reduced the MDA
concentration to 10%, 8%, 8% and 6% in the plasma, liver,
neocortex and hippocampus, respectively, when compared to
controls (Table 1).
3.3. EPR SOH radical with DMPO and α-crystallin
Fig. 5a shows the EPR spectrum of the DMPO/·OH adducts,
a 1:2:2:1 quartet (aN=14.87 G, aH β=14.82 G), observed when
DMPO reacted with ·OH generated by the Fenton system.
When a similar reaction was carried out in the presence of α-
crystallin, EPR signals of lower intensity were observed. This
inhibition depended strongly on α-crystallin concentration (Fig.
5b–d). BSA was used as a positive control (Fig. 5e). BecauseFig. 4. The effect of α-crystallin pretreatment on nitric oxide levels in the
plasma, liver, neocortex and hippocampus homogenates of inflammation-
induced mice. Bar represents the group mean±S.D. for six animals. Different
superscripts indicate significant difference between groups (Pb0.05).the EPR signal of DMPO/SOH, measured in the absence of α-
crystallin, was unaffected by the addition of α-crystallin, it was
concluded that these less intense signals resulted from true
inhibition of DMPO/·OH formation that occurred via scaveng-
ing of ·OH by α-crystallin.
3.4. In vitro astrocyte experiments
LPS exposure was significantly increased in LPO level, NO
and SOH production in the astrocyte as compared to control
(Fig. 6a–c). Our result show that α-crystallin pretreatment
significantly prevent LPS induced LPO levels, NO and SOH
production in the astrocytes (Fig. 6a–c).
3.5. Calcium
Free intracellular calcium is one of the most important
messengers for many signal transduction pathways of neurons;
alterations in intracellular calcium homeostasis are critically
involved in brain aging, memory and cell death. The present
result indicated that the basal intracellular Ca2+ concentration
([Ca2+]i), determined by calcium sensitive fluorescent dye
FURA-2AM, is significantly higher (Pb0.05) in the lym-
phocytes, hepatocytes and astrocytes of the inflammation
induced mice than in control. α-Crystallin therapy signifi-
cantly reduces inflammation induced intracellular Ca2+
concentration (Fig. 7) in the mice lymphocytes, hepatocytes
and astrocytes.
3.6. Glucose
Brain depends upon continuous glucose metabolism for
normal function. Even minimal interruption of brain glucose
metabolism impairs brain function. The present result shows
that glucose concentration was significantly reduced in the
neocortex and hippocampus (Pb0.05) of inflammation-induced
mice when compared to control and α-crystallin treated groups
Fig. 5. EPR spectra of DMPO/OH obtained at various concentration of α-crystallin. Spectra a–d correspond to α-crystallin of 0, 1.0 μg, 1.5 μg, and 2.0 μg,
respectively. [DMPO]=1 mM, pH 7.0 phosphate buffer (10 mM). Spectra e corresponds to 3 μg of BSA as positive control. Instrumental settings: microwave power
2.0 mW, modulation amplitude 5.00 G, receiver gain 5.02e+003, time constant 5.120 ms.
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glucose uptake and thus by maintaining continuous metabolism
of glucose.
3.7. Acetylcholine (Ach)/Acetylcholine esterase (AChE)
The activity of AChE, the enzyme responsible for
acetylcholine degradation, was significantly increased
(Pb0.05) in the inflammation-induced mice when compared
to control. α-Crystallin treatment significantly reduces the
inflammation induced AChE activity in the α-crystallin
treated group (Table. 2). In contrast, ACh was significantly
decreased in the inflammation-induced mice when compared
to control. Our result showed that α-crystallin treatment
protects the mice from inflammation induced acetylcholine
degradation.4. Discussion
One of the pivotal hallmarks of neuroinflammation is
activated glia [31]. Activated glial cells astrocytes and/or
microglia produce a variety of factors which can mediate
neuronal death; they include reactive oxygen species (ROS),
nitric oxide, and pro-inflammatory cytokines. These major
triggers are not normally found in excess in the brain but may be
synergistically produced during systemic inflammation and
may be transported across from circulation. In our previous
studies, we have shown induction of silver nitrate stimulate
inflammatory cells to release a plethora of cytokines and ROS in
the circulatory system, which are transported to various parts of
the body [12,32].
In the present study, we report molecular chaperone α-
crystallin exerts a protective effect against detrimental effects
Fig. 6. (a) The suppressive effect of α-crystallin on LPO induced by exogenously added LPS in neonatal mice cerebral cortical cells incubated at 37 °C. Bar represents
the group mean±S.D. Different superscripts indicate significant difference between groups (Pb0.05). (b) NO levels released by LPS-treated astrocytes. Bar diagram
represents the group mean±S.D. (c) EPR spectra of DMPO/OH obtained Spectra: (i) Control, (ii) LPS (100 nm/ml LPS alone) and (iii) 100 nm/ml LPS + α-crystallin 2
μg/ml treated. [DMPO] = 1 mmol, pH 7.0 phosphate buffer (10 mmol). Instrumental settings: microwave power 4.024 mW, modulation amplitude 3.00 G, receiver
gain 7.10e+003, Signal channel conversion 20.480 ms, time constant 2.560 ms, sweep time 20.972.
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intraperitoneal injection (IP) of α-crystallin scavenge ROS in
the circulating system thereby minimize astrocytes produced
ROS in the inflammation induced mice [12]. Our present
results point out to the fact that a pharmacological
administration of α-crystallin prevents the elevation of
GFAP content induced by acute inflammation (Fig. 1c)
thereby acting as an anti-inflammatory agent. Early workers
have shown that intravenous injection of therapeutic protein
into animals resulted in a rapid rise in circulating levels of
protein followed by a fast decline. However intraperitoneal
injection (IP) resulted in moderate rise in the level of serum
leading to slow delivery of the protein. IP is the preferred
method for the better organ distribution of the therapeuticprotein [33–37]. For instance, IP route delivery of BAM-10, a
monoclonal antibody recognizing the N terminus of Aβ, fully
reversed memory decline in Tg2576 mice due to moderate
central nervous system penetration leading amyloid plaque
dissolution [36]. The protein delivery barrier in IP consists of
surrounding cells, extracellular matrix, and blood microves-
sels. It is been observed that peritoneum is highly permeable
to proteins of therapeutic value [37]. The exact mechanism of
such delivery is yet to be worked out.
Our results also indicate increased expression of tran-
scription factor NFκB in the neocortex and liver of
inflammation induced mice (Figs. 2b and 3b); α-crystallin
pretreatment prevents the activation of the transcription
factor NFκB in the liver and neocortex. (Figs. 2c and 3c).
Fig. 7. The effect of α-crystallin pretreatment on cytoplasmic Ca2+ concentration
in the lymphocytes, hepatocytes and astrocytes of inflammation-induced mice
that were measured by dual-wavelength spectrophotometry using FURA-2AM
as indicator. Each data point represents the mean of six animals. Bar represents
the group mean±S.D. for six animals. Different superscripts indicate significant
difference between groups (Pb0.05).
Table 2
Effect of α-crystallin treatment on the levels of glucose, acetylcholine and
acetylcholinesterase activity in the neocortex and hippocampus of inflammation
induced mice
Regions Parameter Control Inflammation α-Crystallin
Neocortex Glucose 70.25±6.24a 50.33±5.21b 63.12±0.14a
Hippocampus 55.24±5.11a 42.13±4.26b 53.21±5.21a
Neocortex AChE 60.13±6.24a 82.52±8.26b 65.36±7.11a
Hippocampus 59.14±5.21a 72.24±7.28b 62.34±6.44a
Neocortex ACh 418.72±39.55a 270.22±26.22b 405.34±38.45a
Hippocampus 426.55±41.51a 291.22±27.52b 411.36±41.81a
Values represent the group mean±S.D. for six animals. Different superscripts
within a row show significant variation between groups, Pb0.05. (Glucose
μg/gm tissue, AChE micromoles acetylthiocholine iodide hydrolyzed/min/mg
protein, Acetylcholine pmol/mg protein.)
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[38,39] has been recognized as a key regulator of the
expression of genes involved in the intracellular redox status.
Moreover, NFκB is also responsible for the regulation of
genes of proinflammatory cytokines and iNOS. Thereby, an
increased expression of iNOS through NFκB leads to an
increased production of NO. Recent studies have reported
cultured astrocytes from inducible NO synthase-knockout
mice, are incapable of induction of NOS [40]. Overproduc-
tion of NO in the brain is a sign of acute brain
inflammation, and can be used to examine anti-inflammatory
actions of administered therapeutic compounds. α-Crystallin
pretreatment prevents NO production (Fig. 4), thus revealing
its anti-inflammatory property. Our in vitro astrocyte
experiment with LPS shows that α-crystallin has a direct
NO scavenging capacity (Fig. 6). Similar evidences of role
of peripheral inflammation induced by LPS leading to
profound glial activation and generation of nitric oxide [41]
further strengthen our observations.
It has been reported that free radicals enhance the oxidative
process and induce lipid peroxidation in cell membrane and
disturb the biochemical and physiological function within the
cell thereby affecting membrane integrity [42]. The present
result indicates a significant increase in LPO in the inflamma-
tion group when compared to control and crystallin treated mice
(Table 1). The reduced level of LPO by α-crystallin is related to
its potentSOH scavenging capacity. Our EPR study shows that
α-crystallin reduced the SOH radical signal in a dose dependent
manner (Fig. 5). The SOH radical scavenging ability of α-
crystallin is further confirmed by our in vitro astrocyte
experiments with LPS (Fig. 6).
Our current study also highlights a significant reduction of
glucose in the neocortex and hippocampus of inflammation
induced mice (Table 1). There are two different glucose
transporters expressed in brain, GLUT1 and GLUT3; GLUT1
is present in endothelial cells and GLUT3 in neurons [43].
LPO can impair the function of, several plasma membrane
proteins involved in maintenance of ion homeostasis
including glucose transporters [44]. Furthermore, recent
studies revealed that NO have an inhibitory action on glucoseuptake and glycolysis [45] Impairment of the glucose
transporters leads to ATP depletion, which in turn leads to
dysfunction of neurons and cell death [46,47]. Treatment with
α-crystallin maintains brain glucose levels in the inflamma-
tion-induced mice, suggesting a possible role for α-crystallin
in scavenging the oxyradicals and thus by maintaining ion
homeostasis and preventing the damage of glucose transpor-
ters by LPO and NO.
There is growing evidence for a possible link between an
increase in Ca2+ and an enhanced generation of ROS [48,49].
We observed an increase in intracellular Ca2+ levels in the
inflammation-induced mice (Fig. 7). Recent reports show that
an increase in cell Ca2+ influx, precedes ROS formation and
subsequent LPO in cultured cells exposed to Aβ [50],
suggesting that the cohesive appearance of these neurotoxic
events may accelerate Aβ-induced neuronal damage [51]. α-
Crystallin therapy suppress brain intracellular Ca2+ levels in the
inflammation induced mice, suggesting a possible role for α-
crystallin in scavenging the free radical and thus by maintaining
ion homeostasis.
The degeneration of the forebrain cholinergic pathways is
yet another hallmark in brain inflammation and is considered
to be the main cause of cognitive impairments in neurode-
generative diseases [52]. In AD brains changes occur in the
expression and distribution of AChE [53]. Here, we report
that inflammation induction leads to a significant (Pb0.05)
increase in AChE activity when compared to control (Table
2). Sberna et al. [54] reported that Aβ increments AChE
activity in P19 cells by increasing calcium entry through L-
type voltage-dependent calcium channels, suggesting that the
increase in AChE expression around amyloid plaques is a
consequence of the disturbance in calcium homeostasis. In
our experimental conditions, we have also observed an
increase in intracellular Ca2+ levels in the inflammation-
induced mice, which in turn related to the increase in AChE
activity. Melo et al. [55] reported that the enhancement of
AChE activity induced by Aβ is mediated by oxidative stress
and vitamin E, a well-known lipid peroxidation chain
breaking antioxidant, and NOS inhibitors (7-Nitroindazole
and L-NAME) prevent Aβ peptide induced AChE activity
enhancement. This evidence suggests a role for LPO and NO
292 J.G. Masilamoni et al. / Biochimica et Biophysica Acta 1762 (2006) 284–293on the increase of AChE activity. Our result shows that α-
crystallin prevents the enhancement of AChE activity in the
inflammation-induced mice by decreasing LPO and NO
production and intracellular calcium levels. Our result further
shows that ACh was significantly reduced in the inflamma-
tion induced mice. This might be due to the increased activity
of AChE and suppress ACh synthesis mainly by inhibiting
glucose metabolism and thereby reducing the availability of
acetyl-CoA for ACh synthesis [56]. Furthermore ACh
synthesis is also prevented by H2O2 and NO [57]. α-
Crystallin, by regulating the glucose transport and optimizing
the AChE activity enhances ACh level in the hippocampus
and neocortex of inflammation induced mice.
In conclusion, our study reveals, α-crystallin an SOH and
NO radical scavenger reduces the neuroinflammation by
reducing LPO, intracellular calcium levels, restoring the
depleted glucose in the brain and suppressing the GFAP,
NFκB expressions. Furthermore, it is also seen to exert a
beneficial action such as decreasing acetylcholine esterase
activity in the neurons thereby rescuing the acetylcholine
levels. Thus α-crystallin therapy might be serving as a potent
therapeutic agent in neuroinflammation.Acknowledgments
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